With money raised by the sales, Stavropoulos and Dow have bought in shares (the number of shares outstanding has shrunk by a fifth in the past five years), bought Eli Lilly's 40% stake in an agricultural chemical joint venture with Dow, and bought the Minnesota-based biotechnology firm Mycogen.
FORBES: Chemical Transformation